This research uncovers that CHNQD-00603 restores osteogenic potential in bone marrow mesenchymal stem cells, suggesting a new treatment for age-related disorders.
CHNQD-00603 mitigates BMSC senescence and restores osteogenic capacity by activating AKT/ERK/mTOR-mediated autophagy, making it a promising therapeutic candidate for the treatment of age-related skeletal disorders.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: